Elizabeth L. Eberle - Concepedia

Author

Elizabeth L. Eberle

Eli Lilly (United States)

Also Known As

Elizabeth Eberle, Elizabeth L. Eberle, Elizabeth Lutz Eberle

Publications

560

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

Elizabeth L. Eberle is an author at Eli Lilly (United States) specializing in medicine, neuroscience, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	395
2	Health Sciences	3	3	168
3	Social Sciences	3	3	123
4	Behavioral Sciences	2	2	41
5	Cognitive Science	1	1	19

Elizabeth L. Eberle

Publications

500

Citations

H-Index

Page 1

	Year	Citations
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders Linda M. Rorick‐Kehn, Jeffrey M. Witkin, Michael A. Statnick, Neuropharmacology Psychoactive DrugPsychiatryFunctional SelectivityMedicineAnimal Models	2013	148
Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing Carrie K. Jones, Elizabeth L. Eberle, Stephen C. Peters, Neuropharmacology InflammationSelective Group IiHealth SciencesAcute PainPain Medicine	2005	86
Pharmacologic Interactions between the Muscarinic Cholinergic and Dopaminergic Systems in the Modulation of Prepulse Inhibition in Rats Carrie K. Jones, Elizabeth L. Eberle, David B. Shaw, Journal of Pharmacology and Experimental Therapeutics	2005	83
Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats Harlan E. Shannon, Elizabeth L. Eberle, Steven Peters Neuropharmacology Anticonvulsant DrugsNeurophysiologyMedicinePhysiologyDiverse Mechanisms	2005	82
The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil Matthew E. Barton, Elizabeth L. Eberle, Harlan E. Shannon European Journal of Pharmacology Molecular PharmacologyHealth SciencesPain MedicineMedicinePhysiology	2005	60
Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats Harlan E. Shannon, Elizabeth L. Eberle, Charles H. Mitch, Neuropharmacology NeuropsychologyBehavioral SciencesBehavioral NeuroscienceAddictionAffective Neuroscience	2007	22
Effects of biasing the location of stimulus presentation, and the muscarinic cholinergic receptor antagonist scopolamine, on performance of a 5-choice serial reaction time attention task in rats Harlan E. Shannon, Elizabeth L. Eberle Behavioural Pharmacology NeuropsychologySelective AttentionCognitionAttentionRelative Frequency	2005	19

Page 1